Animal models of inflammatory bowel disease

Drug Discovery Today: Disease Models

Volumn 1, Issue 4, 2004, Pages 437-443

  Borm, Michelle E A ^a   Bouma, Gerd ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; OXAZOLONE; STAT4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRINITROBENZENESULFONIC ACID;

CELL LINE; CHROMOSOME 9; COMBINED IMMUNODEFICIENCY; CROHN DISEASE; ENTERITIS; GASTROINTESTINAL TRACT; GENETIC ANALYSIS; GENETIC ENGINEERING; GUINEA PIG; HEREDITY; IN VITRO STUDY; IN VIVO STUDY; INTESTINE CELL; INTESTINE EPITHELIUM; INTESTINE MUCOSA; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; QUANTITATIVE TRAIT LOCUS; RABBIT; REVIEW; T LYMPHOCYTE; ULCERATIVE COLITIS;

EID: 23744463126     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2004.11.019     Document Type: Article

References (45)

1. Bouma, G. and Strober, W. (2003) The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3, 521-533
2. Loftus, E.V. Jr (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126, 1504-1517
3. Bonen, D.K. and Cho, J.H. (2003) The genetics of inflammatory bowel disease. Gastroenterology 124, 521-536
4. Hugot, J.P. et al. (1996) Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379, 821-823
5. Hugot, J.P. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603
6. Ogura, Y. et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606
7. Buset, M. et al. (1986) Inhibition of human colonic epithelial cell proliferation in vivo and in vitro by calcium. Cancer Res 46, 5426-5430
8. Fogh, J. et al. (1977) Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst. 58, 209-214
9. Sanderson, I.R. et al. (1996) Human fetal enterocytes in vitro: modulation of the phenotype by extracellular matrix. Proc. Natl. Acad. Sci. USA 93, 7717-7722
10. Strober, W. et al. (2002) The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20, 495-549
11. Kraft, S.C. et al. (1963) Histologic and immunohistochemical features of the Auer "Colitis" in rabbits. Am. J. Pathol. 43, 913-927
12. Onderdonk, A.B. et al. (1983) Enhancement of experimental ulcerative colitis by immunization with Bacteroides vulgatus. Infect. Immun. 42, 783-788
13. Taurog, J.D. et al. (1994) The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J. Exp. Med. 180, 2359-2364
14. Rath, H.C. et al. (2001) Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect. Immun. 69, 2277-2285
15. Halpern B. et al. (1967) Experimental immune ulcerative colitis. Immunopathology, International Symposium, 1967, Basel/Stuttgart, Switserland/Germany (pp. 161-178) Schwalbe and Co
16. O'Garra, A. and Vieira, P. (2004) Regulatory T cells and mechanisms of immune system control. Nat. Med. 10, 801-805
17. Powrie, F. et al. (1993) Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 seid mice. Int. Immunol. 5, 1461-1471
18. Chalifoux, L.V. and Bronson, R.T. (1981) Colonic adenocarcinoma associated with chronic colitis in cotton top marmosets, Saguinus oedipus. Gastroenterology 80 (5 Pt 1), 942-946
19. Watkins, P.E. et al. (1997) Treatment of ulcerative colitis in the cottontop tamarin using antibody to tumour necrosis factor alpha. Gut 40, 628-633
20. Matsumoto, S. et al. (1998) Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut 43, 71-78
21. Ogura, Y. et al. (2001) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 276, 4812-4818
22. Watanabe, T. et al. (2004) NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5, 800-808
23. Becker, K.G. et al. (1998) Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl. Acad. Sci. USA 95, 9979-9984
24. Mahler, M. et al. (1999) Genetic analysis of susceptibility to dextran sulfate sodium-induced colitis in mice. Genomics 55, 147-156
25. Farmer, M.A. et al. (2001) A major quantitative trait locus on chromosome 3 controls colitis severity in IL-10-deficient mice. Proc. Natl. Acad. Sci. USA 98, 13820-13825
26. Borm M.E.A. et al. A major quantitative trait locus on mouse chromosome 3 is involved in disease susceptibility in different colitis models. Gastroenterology (in press)
27. Bouma, G. et al. (2002) Experimental murine colitis is regulated by two genetic loci, including one on chromosome 11 that regulates IL-12 responses. Gastroenterology 123, 554-565
28. Kozaiwa, K. et al. (2003) Identification of a quantitative trait locus for ileitis in a spontaneous mouse model of Crohn's disease: SAMP1/YitFc. Gastroenterology 125, 477-490
29. Teuscher, C. et al. (1999) Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis. J. Immunol. 163, 2262-2266
30. Morahan, G. et al. (2001) Linkage disequilibrium of a type 1 diabetes susceptibility locus with a regulatory IL12B allele. Nat. Genet. 27, 218-221
31. Mannon P et al. (2004) Anti-interleukin-12 treats active Crohn's Disease. Digestive Diseases Week, International Symposium, 2004, New Orleans, USA (Abstract 162)
32. Zwiers A. et al. Definition of polymorphisms and haplotypes in the interleukin 12B gene: association with IL-12 production but not with Crohn's disease. Genes Immun. (in press)
33. Neurath, M. et al. (2000) TNBS-colitis. Int. Rev. Immunol. 19, 51-62
34. Kim, H.S. and Berstad, A. (1992) Experimental colitis in animal models. Scand. J. Gastroenterol. 27, 529-537
35. Okayasu, I. et al. (1990) A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98, 694-702
36. Gaudio, E. et al. (1999) Dextran sulfate sodium (DSS) colitis in rats: clinical, structural, and ultrastructural aspects. Dig. Dis. Sci. 44, 1458-1475
37. Iwanaga, T. et al. (1994) Morphological analysis of acute ulcerative colitis experimentally induced by dextran sulfate sodium in the guinea pig: some possible mechanisms of cecal ulceration. J. Gastroenterol. 29, 430-438
38. Boirivant, M. et al. (1998) Oxazalone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med. 188, 129-139
39. Ekstrom, G.M. and Andersson, S.E. (2000) Plasma exudation, hyperaemia, and epithelial permeability in rats with oxazolone-induced colitis: modulatory effects of budesonide. Scand. J. Gastroenterol. 35, 190-197
40. Kuhn, R. et al. (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263-274
41. Shull, M.M. et al. (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359, 693-699
42. Wang, B. et al. (1994) A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc. Natl. Acad. Sci. USA 91, 9402-9406
43. Rudolph, U. et al. (1995) Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat. Genet. 10, 143-150
44. Mombaerts, P. et al. (1993) Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75, 274-282
45. Wirtz, S. et al. (1999) Cutting edge: chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens. J. Immunol. 162, 1884-1888